Beneficial effects of platelet-rich plasma on improvement of pain severity and physical disability in patients with plantar fasciitis: A randomized trial

Vahdatpour, Babak; Kianimehr, Lida; Moradi, Ahmad; Haghighat, Shila

Beneficial effects of platelet-rich plasma on improvement of pain severity and physical disability in patients with plantar fasciitis: A randomized trial

Document Type : Original Article

Authors

¹ Department of Physical Medicine and Rehabilitation, Isfahan University of Medical Sciences, Isfahan, Iran

² Department of Radiology, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: The present study aimed to clinically examine the effects of platelet-rich plasma (PRP) on improvement of plantar fasciitis and its related manifestations.
Patients and Methods: This single-blind randomized controlled trial was performed on 32 consecutive patients with the final diagnosis of plantar fasciitis that were randomly assigned to the case group (that received PRP, n = 16) and the control group (that received corticosteroid as methylprednisolone 1 ml plus lidocaine 1 ml, n = 16). The endpoints in the present study were changes in the visual analog scale score and the modified Roles and Maudsley score (RMS) from baseline, 1-month, 3 months, and 6 months follow-up. Plantar fascia was also assessed by B-mode sonography before and also 3 months after primary assessment.
Results: Regarding the pain severity, the PRP group had significantly higher mean pain score at 3 time points of before injection, as well as 1 and 3 months after PRP use when compared to the corticosteroid group (P < 0.05); however, the control group experienced significantly higher pain severity than the PRP group at 6 months after interventions. Also, RMS was lower in PRP group than in corticosteroid group at baseline as well as at 1 and 3 months after injections (P < 0.05). In sonography assessment, no difference was revealed.
Conclusion: Administration of PRP leads to significant improvement in pain severity and physical limitation in patients with plantar fasciitis. This healing effect may be begun at least 3 months after injection.

Keywords

References

1.	Buchbinder R. Clinical practice. Plantar fasciitis. N Engl J Med 2004;350:2159-66.
2.	Martin RL, Davenport TE, Reischl SF, McPoil TG, Matheson JW, Wukich DK, et al. Heel pain-plantar fasciitis: Revision 2014. J Orthop Sports Phys Ther 2014;44:A1-33.
3.	Schwartz EN, Su J. Plantar fasciitis: A concise review. Perm J 2014;18:e105-7.
4.	Molloy LA. Managing chronic plantar fasciitis: When conservative strategies fail. JAAPA 2012;25:48, 50, 52-3.
5.	Rosenbaum AJ, DiPreta JA, Misener D. Plantar heel pain. Med Clin North Am 2014;98:339-52.
6.	Lareau CR, Sawyer GA, Wang JH, DiGiovanni CW. Plantar and medial heel pain: Diagnosis and management. J Am Acad Orthop Surg 2014;22:372-80.
7.	Cutts S, Obi N, Pasapula C, Chan W. Plantar fasciitis. Ann R Coll Surg Engl 2012;94:539-42.
8.	Salvi AE. Targeting the plantar fascia for corticosteroid injection. J Foot Ankle Surg 2014;23:567-85.
9.	Dastgir N. Extracorporeal shock wave therapy for treatment of plantar fasciitis. J Pak Med Assoc 2014;64:675-8.
10.	Johnson RE, Haas K, Lindow K, Shields R. Plantar fasciitis: What is the diagnosis and treatment? Orthop Nurs 2014;33:198-204.
11.	Podolsky R, Kalichman L. Taping for plantar fasciitis. J Back Musculoskelet Rehabil 2014:63:543-5.
12.	Ogden JA, Alvarez RG, Marlow M. Shockwave therapy for chronic proximal plantar fasciitis: A meta-analysis. Foot Ankle Int 2002;23:301-8.
13.	Borrione P, Gianfrancesco AD, Pereira MT, Pigozzi F. Platelet-rich plasma in muscle healing. Am J Phys Med Rehabil 2010;89:854-61.
14.	Yu W, Wang J, Yin J. Platelet-rich plasma: A promising product for treatment of peripheral nerve regeneration after nerve injury. Int J Neurosci 2011;121:176-80.
15.	Arora NS, Ramanayake T, Ren YF, Romanos GE. Platelet-rich plasma: A literature review. Implant Dent 2009;18:303-10.
16.	Marx RE. Platelet-rich plasma: Evidence to support its use. J Oral Maxillofac Surg 2004;62:489-96.
17.	Monto RR. Platelet-rich plasma efficacy versus corticosteroid injection treatment for chronic severe plantar fasciitis. Foot Ankle Int 2014;35:313-8.
18.	Monto RR. Platelet-rich plasma and plantar fasciitis. Sports Med Arthrosc 2013;21:220-4.
19.	Sonnleitner D, Huemer P, Sullivan DY. A simplified technique for producing platelet-rich plasma and platelet concentrate for intraoral bone grafting techniques: A technical note. Int J Oral Maxillofac Implants 2000;15:879-82.
20.	Franceschi F, Papalia R, Franceschetti E, Paciotti M, Maffulli N, Denaro V. Platelet-rich plasma injections for chronic plantar fasciopathy: A systematic review. Br Med Bull 2014;112:83-95.
21.	Vannini F, Di Matteo B, Filardo G, Kon E, Marcacci M, Giannini S. Platelet-rich plasma for foot and ankle pathologies: A systematic review. Foot Ankle Surg 2014;20:2-9.
22.	Shetty VD, Dhillon M, Hegde C, Jagtap P, Shetty S. A study to compare the efficacy of corticosteroid therapy with platelet-rich plasma therapy in recalcitrant plantar fasciitis: A preliminary report. Foot Ankle Surg 2014;20:10-3.
23.	O'Malley MJ, Vosseller JT, Gu Y. Successful use of platelet-rich plasma for chronic plantar fasciitis. HSS J 2013;9:129-33.
24.	Molloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med 2003;33:381-94.
25.	Martinelli N, Marinozzi A, Carnì S, Trovato U, Bianchi A, Denaro V. Platelet-rich plasma injections for chronic plantar fasciitis. Int Orthop 2013;37:839-42.

Advanced Biomedical Research